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ABSTRACT 
This paper presents a patented smart point-of-care testing 
(POCT) system for the diagnosis and grading of peripheral 
neuropathy at the patient’s home or care center. The device aims 
to detect changes or worsening of a patient’s neuropathy.  
Our system utilizes the vibration motor within a smart-
phone, applied through a 3D printed probe attachment to detect 
sensation loss in vibration sensitivity threshold (VST). A 
smartphone app displays several neuropathy questionnaires to 
the user to identify and monitor changes in their condition.  
This paper presents results from comparison between the 
new smart device and the gold standard Neurothesiometer. 
Results suggest that the new device performs closely to the gold 
standard in terms of the frequency and amplitude of vibration. 
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INTRODUCTION 
Peripheral neuropathy is a nerve damage condition. The 
number of patients suffering is large including 10% of over 55s. 
This commonly occurs in patients suffering from cancer or 
diabetes, two of the most common diseases worldwide. 
Diabetes affects 3.8 million people in the UK (7.4% of the 
population). Of all diabetes patients, 60% suffer peripheral 
neuropathy, causing loss of sensation in fingers and toes. 
This POCT neuropathy diagnosis system avoids the 
requirement for patients to travel to a hospital, freeing 
consultation time for clinicians, using wireless data to provide a 
comprehensive objective assessment and detect changes in the 
patient’s condition. Resulting data is transferred to clinicians 
through an online patient portal database which tracks the history 
of each patient’s condition over time.  
Our smart device aims to identify warning signs of 
neuropathy to provide indication of a patient beginning to suffer 
from diabetic limb loss. Neurosthesiometers and other 
Neurologic screening tests such as 10g monofilament and 
biothesiometers have previously been used as the gold standard 
to identify and monitor the progression of neuropathy, and to 
identify the dosage of preventive strategies. The current gold 
standard Neurothesiometer produces a vibration with frequency 
fixed at 110Hz and the amplitude is adjustable by the user 
controls. 
POCT has been used for other conditions such as 
haemostatic dysfunction, gonorrhea or HIV [1]. Previous POCT 
neuropathy devices have been simple, not incorporating any 
questionnaires or online data collection, limiting their use. The 
VibraTip (McCallan Medical) is a handheld key-fob device to 
test vibration sensitivity. This was found to be comparable to the 
neurothesiometer, and superior to the tuning fork [2].  
Alternative devices include the 128Hz electronic tuning fork 
(ETF) [3], thermal stimulus [4] or ultrasound scanning of fibers. 
A patent was filed for a vibration pen pocket device utilized for 
detecting severe neuropathy [5]. The device is shaped like a pen 
including a stimulus probe mounted at the tip. The probe vibrates 
and is applied to a patient's extremity in order to determine if the 
patient can feel the vibration. 
The clinical requirement for a neuropathy device is to test a 
wide range of sensation on the patient’s skin, so that very low 
vibration should be possible, for patients who are only beginning 
to suffer sensation loss. This requires the device to have full 
control of the vibration strength onto the skin surface. 
Human sensation of vibration is operated through small 
fibers of sensation. These small fibers should be activated at the 
frequency of device vibration. The frequency of fiber activation 
is known through previous literature [6]. 
DESIGN AND DEVELOPMENT 
In response to the lack of suitable point-of-care solutions for 
the testing of peripheral neuropathy, we have designed the 
“NEuRopathy evaluation using the Vibration function of a 
mobile phonE” (NERVE) device. Two patents have been filed 
for the NERVE device in UK and Internationally (see 
acknowledgements). The design consists of a smartphone app 
and also a 3D printed attachment. The design steps are shown in 
the following sections. 
Our NERVE device uses a smartphone vibration motor. 
Mobile devices commonly vibrate at 130Hz - 180Hz, an average 
160Hz (9600rpm) based on analysis of the motor manufacturer 
specifications [7]. The optimum frequency for the best 
vibrotactile perception for static state is 151Hz [7]. 
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An app was produced which is compatible with many 
popular mobile phones, tablets and devices. This enables any 
patient with a mobile device to use the developed app at their 
home unaided. For our initial proof of concept system, the 
Android mobile operating system was used with a Samsung 
Galaxy Fame smartphone. 
GEOMETRIC 3D SCANNING THE MOBILE DEVICE 
 Initially the 3D geometry of the mobile device needed to be 
measured, so that we could design an attachment to exactly 
match the shape of the mobile phone. Laser scanning of the 3D 
volume of the phone was completed using an optical scanner 
which captured the precise size and shape of the mobile phone 
contours on both sides and the top. Laser scanning ensures that 
the attachments fit perfectly onto the phone.  Fig. 1. Shows the 
raw volume data obtained from the 3D laser scan. There are 
several imperfections in the data, due to the reflective areas of 
the mobile device which relected the laser beams. Fine chalk dust 
was aplied to the surface to improve the laser detection on 
reflective areas. 
 
 
Fig. 1. Raw data from 3D Laser scan. 
MODELLING THE CAD ATTACHMENT 
 Computer aided design (CAD) models were created 
matching the external geometrical shape of the phone. A uniform 
3mm wall thickness was used to ensure consistency. The volume 
of the mobile phone was subtracted from a block so that the 
phone fits perfectly into the resulting cavity. The attachments 
were designed to connect onto the top or side of the phone. Three 
main designs were printed (Fig. 2.): (i) A 36mm pointed spike. 
(ii) A rod with a rounded end matching diameter of the 
neurosethisomer. (iii) A helix having some spring properties for 
enabling resonance and damping. Once the CAD models were 
completed they were converted into STL format for 3D printing. 
 The attachments aim to apply the vibration in a controlled 
way through a tip which is shaped in the optimal way to transfer 
the vibration according to predefined mechanical vibration 
characteristics. 
 
 
Fig. 2. Three CAD vibration attachments for 3D printing. 
THE 3D PRINTING OF THE PROBE 
 The parts were manufactured on two different 3D printing 
machines for comparison: Stratasys and Makerbot (Fig. 3). The 
CAD models had been designed using a true 1:1 scale in the 
software. Precision caliper measurements were taken from the 
mobile device and compared to measurements from 3D scanning 
to ensure correct thickness measurements. Due to this, the parts 
were printed using the size scales defined within the CAD 
software, so that they fitted perfectly onto the mobile device. 
Using this method the 3D printed probe fits tightly onto the top 
of the phone, holding on by its own friction grip.  
 
 
Fig. 3. The range of 3D printed phone attachments. 
 
 A close contact between the device and attachment is vital. It 
is important that the metallic rim of the mobile phone device 
comes into direct and full contact with the solid part of the 
attachment, to ensure that the full vibration is transferred from 
the phone into that attachment. The metal rim of the mobile 
device transfers the vibration, as the plastic phone cover does not 
fully vibrate with the phone vibration.  
 The current 3D printed devices grip onto the mobile device 
using friction from their precise thickness. However we have 
also designed a one-fits-all attachment for patients owning 
several mobile devices of varying thickness. Two one-fits-all 
attachments were designed which enable the attachment to fit 
various device thicknesses, using a screw to tighten the 
attachment onto the device or a bulldog clip design. 
 A benefit of using plastic ABS material for the attachments 
is that they are cheap and disposable, so they could be given to 
the patients, or sold with little cost. Plastics have aesthetic 
temperature qualities as opposed to metal which is cold against 
the skin, which may cause patient discomfort. The initial parts 
were 3D printed for rapid manufacturing, however if mass 
produced, a range of alternative production approaches could 
ensure cheaper mass production. For mass production these 
initial 3D printed prototypes would serve as a mold for larger 
scale milling or injection molding to yield cheaper unit pricing. 
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APP SOFTWARE USER INTERFACE DESIGN 
 The software system uses a smart-phone app to assess the 
patient’s neuropathy condition. The app could be used with all 
popular models of mobile phones, tablets and devices. This could 
enable any patient with a mobile device to use the developed app 
at their home unaided. For our initial proof of concept system, 
the Android mobile operating system was used since it has the 
largest installed base of any OS, with over 1 billion active 
monthly users, and is selling more than Windows, iOS and Mac 
OS combined. The smartphone used is a Samsung Galaxy Fame, 
which is commonly available since Samsung currently sell more 
smart-phones than all other manufacturers combined [8]. 
 Existing neuropathy questionnaires from clinical literature 
were programmed into a series of simplified data screen in the 
app. The user is asked whether they feel worsening sensations in 
their hands, feet, toes, such as tingling, numbness, and burning. 
This could include temperature change, burning, stabbing and 
cramping in arms, hands. A screen requests the user to indicate 
which common activities they are experiencing increased trouble 
with achieving unaided, such as doing up buttons, tying 
shoelaces, cooking, using cutlery and others. An algorithm was 
devised which takes into account the patient’s answers to these 
questions to produce a final score and grading of neuropathy. 
This algorithm may help to grade neuropathy, or could refer 
patient responses back to the clinician to produce a grading. 
 A series of screens were devised, aiming to minimize 
complexity taking into account elderly patients may be 
unfamiliar with use of apps (Fig. 4). The screens are (i) front 
page, (ii) screen for entering name and age. (iii) a questionnaire 
regarding sensation changes, (iv) questions regarding difficulties 
experienced during common everyday activities, (v) select 
vibration for hands, feet of knees, (vi) a diagram with video 
showing instructions for attaching the probe and holding the 
device (vii) the screen during which vibration occurs and the user 
can select whether they feel a sensation (viii) A results screen 
displaying the patient name, age, VST, results, GPS location. 
 
 
Fig. 4. Screens designed for user interface. 
 Data from geostationary positioning satellite (GPS) and 
wireless network data is used to identify a street address of the 
patient’s current location. This is sent back to the clinicians, who 
are keen to use GPS locations to analyse links between 
geographical location and neuropathy, especially if the app is 
used over a wide geographical population. 
 The app asks the user for their age and how many years they 
have had diabetes (if applicable). This data can be used to detect 
any link between age and neuropathy. 
 When the vibration motor is started on screen 7 (Fig. 4), the 
user is asked whether they feel the vibration and can answer yes 
or no. If no is selected, the vibration strength increases. When 
the user subsequently answers yes, they feel a vibration, that 
current level of vibration is stored as the patient’s current 
vibration sensitivity threshold (VST). 
 The NERVE device with the app running on the mobile 
phone and attachment is shown in Fig. 5.  
 
 
Fig. 5. Complete POCT neuropathy diagnosis system. 
DYNAMIC VIBRATION MODULATION 
 An important aspect of testing neuropathy is to adjust the 
vibration strength, so that individuals of a wide range of 
sensitivities can be tested. This is achieved in the NERVE device 
by adjusting vibration strength in the App and by the design of 
the probe to transmit to vibration onto the patient’s skin. The 
modulation steps and vibration testing steps are described in this 
section. 
BACKGROUND OF MOBILE VIBRATION MOTORS 
 Vibration motors inside mobile phones are used as a haptic 
method to alert the user without using any audio output. Since 
the aim of mobile vibration function is usually to simply produce 
any noticeable sensation to alert the user, a full characterization 
of the vibrations emitted from mobile devices in terms of 
amplitude and frequency may not previously have been 
necessarily completed during manufacture.  
 Vibration motors come in various designs depending on 
manufacturer of the mobile device. The method of vibration used 
within vibration motors is an offset mass mounted onto the motor 
axle. Vibration motors have several variables: (i) axle length (ii) 
mass of the offset (iii) offset length (iv) supply voltage. The 
output vibration can be characterized in terms of (i) displacement 
or amplitude, (ii) force amplitude, (iii) frequency and (iv) 
electrical parameters. Previous research found that when 
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approaching resonance, power increases drastically while 
resistance drops. 
 Various vibration motor designs are in use in mobile devices. 
Samsung Galaxy S3 and Sony Xperia use flat coin vibration 
motors with net weight of 6g. Alternatively iPhone uses a 
cylinder motor design. The offset mass can be either circular or 
semi-circular. The axle diameter can range from 1mm to 4mm, 
external diameter from 3mm to 5mm. Operating voltage varies 
on a range of 2.5-3.8V for vibration motors. The required current 
for the coin motor is roughly 0.033 amps per volt supplied, which 
equates to around 0.1A for a 3V motor.  
 When the vibration motor spins it exerts the vibrational force 
mainly on two axes which are the axes directions towards which 
the eccentric mass move. The attachment should be mounted on 
one of these two axes. Over time if the voltage and amplitude 
supplied to the motor varies, both the frequency and amplitude 
change. At high motor speeds, other aspects such as the flexion 
in the motor shaft will also affect the vibration. 
VIBRATION MODULATION IN THE NERVE APP 
 Mobile phones do not natively provide any hardware or 
software methods to control the strength of motor vibration, only 
on and off controls are provided. There are recently some haptic 
effect apps designed for smartphones which can produce various 
haptic effects, primarily used in games, for example shooting or 
driving. Those haptic effects were not suitable for our device, 
which requires fine-tuned control. 
 In order to modulate the phone’s natural vibration frequency, 
a software app was programmed to control the motor speed. 
Within our developed app, a software method was developed to 
control the motor power. Controlling the vibrator power through 
software caused simultaneous adjustment of both frequency and 
amplitude of vibration, although one cannot be controlled 
independently of the other, since this is inherent to the device. 
This is similar to harmonic force vibration [9].  
 The lowest possible programmable vibration level of the 
phone is described as 20%. If any less than 20% power is 
supplied, then the motor physically stops turning.   
MEASUREMENT OF THE NERVE DEVICE VIBRATION 
 The aim of the vibration measurement test was to compare 
the NERVE device to the current gold standard 
Neurothesiometer device. The experiments were done by 
comparing amplitude and frequency of the two devices. 
Frequency (Hz) was measured by audio analysis, because the 
audio frequency matches mechanical frequency, a principle used 
by the tuning fork. Amplitude (μm) was calculated indirectly by 
measuring the acceleration (m/s2) using accelerometers and then 
using an equation to convert frequency and acceleration into 
displacement (μm). 
 The results show that the NERVE device is equivalent to the 
Neurothesiometer. The NERVE device should be used on 
settings 22% - 26%, which produce frequency 100 - 135Hz and 
amplitude 1.3μm. This is equivalent to the neurothesiometer 
setting 4 (28V), which produces frequency 110Hz and amplitude 
1.3μm. This ensures the frequency stays within the ideal range 
for human perception. 
ACCELEROMETER MEASUREMENTS  
Accelerometers were used to record the motion of the NERVE 
device (Fig. 6) and neurothesiometer (Fig. 7) when vibrating at 
each setting. Using this recorded accelerometer data, the 
maximum accelerations were measured for each NERVE setting 
in Table 1 and for Neurothesiometer in Table 2. 
 
 
Fig. 6. NERVE device Accelerometer data for each setting. 
 
Fig. 7. Neurothesiometer Accelerometer data for each setting. 
 
 0% 20% 26% 32% 50% 100% 200% 
max 0.20 0.43 1.19 1.91 2.10 2.29 2.48 
min 0.09 
-
0.42 
-
1.05 
-
1.76 
-
1.97 -2.23 -2.25 
range 0.10 0.85 2.25 3.68 4.07 4.53 4.73 
Table 1. NERVE device Acceleration (m/s2) - Min and Max over 
20 seconds. 
 
 0 
(0V) 
2 
(20V) 
4 
(28V) 
6 
(36V) 
8 
(44V) 
10 
(49V) 
max 0.045 0.316 5.245 8.559 9.112 8.789 
min 
-
0.062 
-
0.924 -7.544 -8.034 -8.439 -9.892 
range 0.107 1.240 12.789 16.594 17.551 18.681 
Table 2. Neurothesiometer Acceleration (m/s2) - Min and Max 
over 20 seconds. 
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FREQUENCY MEASUREMENT BY AUDIO ANALYSIS 
 Unfortunately the accelerometer recordings could not 
identify the frequency (Hz), because the fastest possible rate the 
accelerometers could be recorded was a sampling rate of 100Hz. 
This is not fast enough to cover the expected 160Hz range of 
mobile phone vibration motors.  
 To solve this problem, audio analysis was used to measure 
frequency. The frequency of mechanical vibration is equal to the 
frequency of audio that it generates, which is the principle used 
in a tuning fork. Audio recordings were captured using a 
microphone. Audio was recorded for all vibration strengths. The 
audio was recorded at a sample rate of 44.1KHz, which is fast 
enough to capture vibrations in the range of 160Hz (0.16KHz). 
For each vibration strength, exactly 100ms audio sample was 
analysed, to count the number of waves which occurred. Audio 
was recorded separately for each neurothesiometer strength 
setting: 2, 4, 6, 8, 10, which equate to voltages of 20V, 30V, 36V, 
45V, 49V. Audio recordings are visualised as a waveform for 
NERVE device in Fig. 8 and Neurothesiometer in Fig. 9.  
NERVE device frequency measurement results (Table 3), show 
that frequency increased as vibration strength increased, from 
90Hz (20%) to 215Hz (200%).  
 Neurothesiometer frequency measurement results (Fig. 9) 
show that as vibration strength setting was increased from 2, 4, 
6, 8 and 10, the frequency remained constant at 110Hz.  
 For both devices, the amplitude increased as the vibration 
strength increased, but in the Fig. 8 and Fig. 9, the amplitudes 
have been normalised to the same vertical scale, to make it easier 
to visually locate the wave peaks. The original time scale is 
preserved on x axis. Increased audio amplitude does not imply 
increased mechanical vibration amplitude, which is why this 
audio data was used to measure frequency, not amplitude. 
 
Speed 
(%) 
Peaks in 0.1 
seconds 
Time period 
(ms) 
Frequency 
(Hz) 
12% Unmeasurable Unmeasurable Unmeasurable 
16% Unmeasurable Unmeasurable Unmeasurable 
20% 9 11.4 90 
22% 10 10 100 
23% 11 9.1 110 
24% 12 8.3 120 
25% 13 7.7 130 
26% 13.5 7.4 135 
28% 15 6.6 150 
29% 16 6.2 160 
30% 17 5.8 170 
32% 17.5 5.7 175 
34% 18 5.5 180 
36% 19 5.2 190 
42% 19.5 5.1 195 
50% 20.5 4.9 205 
100% 21 4.7 210 
200% 21.5 4.6 215 
Table 3. NERVE device - Frequency of each vibration strength 
determined by audio analysis. 
 
Fig. 8. NERVE device audio recordings showing vibration 
frequency changes on all strength settings. 
 
 
Fig. 9. Neurothesiometer Audio recordings showing vibration 
frequency at all settings. The red ovals show frequency peaks 
constant at 110Hz on all settings. 
AMPLITUDE CALCULATIONS USING EQUATION 
 The amplitude of vibration was calculated using Equation 1, 
as the displacement x based on the known acceleration a and 
frequency f: 
 
𝑥 =  
𝑎
−(2𝜋𝑓)2  
     (1) 
 
where a = acceleration in m/s2, f = frequency in Hz, x = 
displacement from the central position in m. 
 The amplitude (mm) is the largest displacement (mm) that 
occurred during the vibration. 
 Theoretically the fastest acceleration occurs at the top and 
bottom of each vibration wave.  Therefore when acceleration is 
at the maximum, the displacement is also at the maximum. In 
both devices, for each strength setting, the maximum 
acceleration (Table 1 and 2) and frequency (Table 3) has been 
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measured. Eq. 1 was used to calculate the maximum 
displacement which occurred during the oscillations, which is 
equal to the vibration amplitude. Calculations of amplitude for 
NERVE device are in Table 4 and Neurothesiometer in Table 5. 
 For the Neurothesiometer, because frequency is fixed, the 
amplitude is linearly related to the acceleration. 
 As the NERVE device uses an offset mass, the amplitude is 
mostly constant irrespective of the speed or frequency, because 
the amplitude directly depends on the length of the offset shaft 
and the relation between offset mass, and mass of mobile phone. 
As frequency increases, more centrifugal force is generated but 
it is changing direction more quickly giving less time to 
accelerate the mobile phone. 
 
 20% 26% 32% 50% 100% 200% 
Maximum 
Accelerometer 
measurement 
(a) (m/s2) 0.42 1.12 1.84 2.03 2.26 2.36 
Audio 
Frequency  
Measurements 
(f) (Hz) 90 140 180 200 210 210 
Displacement 
= Amplitude 
in 
micrometers  
(x) (μm) 
1.34 1.45 1.44 1.29 1.30 1.36 
Table 4. NERVE device – Calculated amplitude of vibration at 
each setting. 
 
 2 
(20V) 
4 
(28V) 
6 
(36V) 
8 
(44V) 
10 
(49V) 
Maximum 
Accelerometer 
measurement 
(a) (m/s2) 0.053 0.620 6.394 8.297 8.775 
Audio 
Frequency  
Measurements 
(f) (Hz) 110 110 110 110 110 
Displacement 
= Amplitude 
in 
micrometers  
(x) (μm) 
0.112 1.298 13.387 17.369 18.371 
Table 5. Neurothesiometer– Calculated amplitude of vibration at 
each setting. 
SUMMARY OF VIBRATION COMPARISON 
 The neurothesiometer has fixed frequency (110Hz), whereas 
the NERVE device has variable frequency (90Hz – 215Hz).  
 The NERVE device has fixed amplitude (~1.3μm) whereas 
the Neurothesiometer has variable amplitude (0.1μm – 18.3μm). 
 
 
Fig. 10 Frequency (Hz) comparison for NERVE device and 
Neurothesiometer.   
 
 
Fig. 11 Amplitude (μm) comparison for NERVE device and 
Neurothesiometer.   
  
 The NERVE setting 26% is closely equivalent to 
Neurothesiometer setting 4 (28V). There is a crossover point 
where the NERVE device and neurothesiometer are equivalent 
in both frequency (Fig. 10) and amplitude (Fig. 11).  
 The NERVE device setting 26% has frequency of 140Hz 
which is close to the 110Hz Neurothesiometer, close to the 
Tuning fork frequency of 128Hz and within the ideal range for 
human perception (100-150Hz). The NERVE device setting 
26% has Amplitude is 1.3μm which is the same amplitude as the 
Neurothesimeter at setting 4 (28V).  
 The point at which the two devices are equivalent is 28V, is 
very close to the normal clinical perception test. Clinicians 
normally consider that patients who cannot sense 25V are 
considered to have neuropathy. 
CLINICAL TRIAL TESTING WITH PATIENTS 
 The device has been tested on a small number of patients 
within Royal Bournemouth Hospital NHS Foundation Trust. The 
data was able to ascertain which levels of vibration various 
patients can feel. Both the patients and clinicians provided 
positive feedback. A further clinical trial is planned in the near 
future to test the phone device on neuropathy patients. The trial 
will assess whether the algorithm can directly grade neuropathy 
from the vibration sensitivity, and to test the automatic alerting 
and referral to a clinician if a patient’s performance decreases. 
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 Initially the gold standard (Neurothesiometer) will be used to 
evaluate peripheral sensitivity. The protocol for testing with the 
neurothesiometer will follow the methods suggested by Duke et 
al (2007). The sensation will be demonstrated first by placing the 
probe against the shoulder. Participants will be asked to lie 
supine on bench with bent legs so that feet (socks and shoes are 
removed) are flat on the bench. The probe will be held at 90 
degrees to the skin with constant pressure. Three sites (big toe, 
ankle and knee) will be used and only the right lower limb will 
be tested (as recommended by Duke et al, 2007). Testing will 
begin with the most extreme point (big toe) and voltage will 
slowly increase from 0V at a rate of 1V/s until the participant 
indicates that they can feel the vibration. This is then repeated 
after 1 minute break. If the mean detection limit in the toe is less 
than 50V, no other sites are tested. For limits greater than 50V 
the process is repeated first at the ankle and then the knee. 
 This is followed by Autonomic Function Testing (AFT) to 
separate sensory tests. Following the AFT, the participant’s 
peripheral sensitivity will be evaluated using the NERVE device. 
First, a demonstration of the vibration will be produced on the 
participant’s shoulder. Following this, the participant will be 
asked to lie supine on the bench with their feet outstretched. The 
vibration probe attached to the phone will be held against the 
fleshy part of the big toe with a constant pressure. The phone’s 
vibration will be increased from 0% until the participant 
indicates they have felt the sensation. This level will be recorded 
by the app. After 1 minute, this will be repeated and the mean % 
used as the outcome. 
INTERPRETATION 
 The aim of this research was to build a point-of-care 
diagnosis system for peripheral neuropathy. Currently the patient 
is required to attend the hospital several times to use a 
neurothesiometer. This system uses an app and vibration motor 
of the smart phone to offer this functionality in the home setting, 
saving cost and time. Measurements can be taken more 
consistently and patient data is accurately recorded.  
 The 3D printed probe fits tightly onto the top of the phone, 
which ensures all of the vibration is transferred. The smart-phone 
attachment fits the phone based on 3D scan data. 
 The app was used on a small number of patients within Royal 
Bournemouth Hospital. Initial results were promising. A further 
structured clinical trial is now being planned. The clinical trial 
will follow well-define statistical approaches to judge relevance 
and success of the device. 
 This is also useful for cancer patients with sensation loss 
caused by chemotherapy. The device may be useful in third 
world countries where mobile devices are common and patients 
are experiencing neuropathy caused by drugs taken for leprosy, 
AIDS and tuberculosis.  
 Patients who do not have neuropathy or are at a very early 
stage but who wish to obtain confirmation of this can also use 
the app, and only when they score a level below a certain 
threshold will they then be advised by the app to consult their 
neuro-physician. 
 Lower VST and sensation loss may also be caused by 
prescribed drugs, rather than peripheral neuropathy, such as 
chemotherapy induced neuropathy or with patients from third-
world countries taking drugs for tuberculosis. 
 We aim to continue further evaluation of the device using 
extracted (physiologically relevant) features from both devices. 
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